NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-115-2016-0-US-01 METHODS OF MAKING 18F-LABELED PRECURSORS AND PEPTIDES, LABELED C-MET BINDING PEPTIDES, AND METHODS OF USE THEREOF US 62/366,246 Abandoned
NHLBI E-121-2016-0-US-01 METHODS OF PRODUCING MODIFIED NATURAL KILLER CELLS AND METHOD OF USE US 62/366,493 Abandoned
NCI E-224-2016-0-US-01 Methods of Detecting Circulating Cell-Free HPV DNA US 62/364,922 Abandoned
NIA E-279-2013-0-US-03 METHODS FOR SELECTIVE INHIBITION OF PLURIPOTENT STEM CELLS US National Stage 15/112,923 10316287 Issued PDF
NIDDK E-761-2013-0-US-06 CGAP-PNA Multivalent Peptide Nucleic Acid Ligand Display US National Stage 15/112,981 Abandoned
NIDDK E-742-2013-0-CN-03 A3 Adenosine Receptor Agonists CN National Stage 201480073564.6 Issued
NCI E-141-2008-0-AU-30 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof AU DIV 2016206235 Issued
NCI E-055-2014-0-US-06 Anti-NY-BR-1 Polypeptides, Proteins, and Chimeric Antigen Receptors US National Stage 15/112,524 Abandoned
NIAAA E-049-2016-0-HK-06 COMPOUND FOR USE IN PROTECTING SKIN HK National Stage 16108511.5 Abandoned
NIAID E-202-2008-0-US-13 Inhibitors of the Plasmodial Surface Anion Channel as Antimalarials US CON 15/213,181 9974796 Issued PDF
NHLBI E-287-2015-1-US-01 Device, Prosthesis And Delivery Systems, Transcatheter MRI-guided Implantable Cavopulmonary Bypass Endograft US 62/363,716 Abandoned
NCATS E-202-2016-0-US-01 Compounds and Methods for Treatment and Prevention of Flavivirus Infection US 62/363,238 Abandoned
NCATS E-043-2017-1-US-01 Pharmaceutical Compositions With Antiflaviviral Activity US 62/362,884 Abandoned
NCI E-050-2014-0-KR-12 Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon KR National Stage 10-2016-7019097 Issued
NICHD E-003-2014-0-US-06 AGENTS THAT SPECIFICALLY BIND MATRILIN-3 AND THEIR USE US National Stage 15/111,773 10323083 Issued PDF
NCI E-340-2007-0-JP-19 MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PRONOSIS AND TREATMENT OF PROSTATE RELATED DISORDERS JP DIV 2016-139495 Abandoned
NCI E-126-2016-0-US-01 IL-15/IL15 Receptor Alpha Treatment Regimens and Use with Therapeutic Vaccines US 62/326,223 Abandoned
NCI E-029-2006-1-EP-21 N-SUBSTITUTED INDENOISOQUINOLINES AND SYNTHESES THEREOF EP DIV 16179274.2 Abandoned
CC E-184-2012-0-HK-09 IMAGEABLE EMBOLIC MICROSPHERE HK EP 16108169.0 Abandoned
NCI E-094-2004-0-US-10 Pharmacodynamic Assays US CON 15/208,324 Abandoned
NCI E-255-2015-2-JP-02 EXPANSION CULTURE METHOD FOR NEPHRON PROGENITOR CELLS HAVING NEPHRON-FORMING CAPACITY JP National Stage 2017-528667 Issued
NIDDK E-284-2008-0-AU-17 Low Molecular Weight Thyroid Stimulating Hormone Receptor (TSHR) Agonists AU DIV 2016204845 Issued
NCI E-255-2015-2-PCT-01 EXPANSION CULTURE METHOD FOR NEPHRON PROGENITOR CELLS HAVING NEPHRON-FORMING CAPACITY PCT PCT COMB PCT/JP2016/070396 Expired
NHLBI E-758-2013-1-US-02 Antibody Targeting Cell Surface Deposited Complement Protein C3d And Use Therof US National Stage 15/110,577 10035848 Issued PDF
NCI E-227-2015-0-PCT-02 ENHANCING ASTROCYTE NEUROPROTECTIVE FUNCTIONS USING P53 ISOFORMS PCT PCT PCT/US2016/041631 Abandoned
NCI E-171-2018-5-US-01 MODIFIED CELLS AND METHODS OF THERAPY US 62/360,245 Abandoned
NHLBI E-758-2013-1-CA-03 ANTIBODY TARGETING CELL SURFACE DEPOSITED COMPLEMENT PROTEIN C3d AND USE THEREOF CA National Stage 2936346 Pending
NCI E-295-2012-0-US-06 Anti-Viral Cnidarins US National Stage 15/110,156 11034736 Issued PDF
NIA E-051-2008-0-US-11 Compositions and Methods for Delivering Inhibitory Oligonucleotides US DIV 15/204,789 10765694 Issued PDF
NCI E-062-2014-0-US-03 RAS PATHWAYS AS MARKERS OF PROTECTION AGAINST HIV AND METHODS TO IMPROVE VACCINE EFFICACY US National Stage 15/110,400 10398772 Issued PDF
NCI E-750-2013-0-CN-05 Methods for Subtyping Lymphoma Types by Means of Expression Profiling CN National Stage 201480072382.7 Issued
NINDS E-252-2016-0-US-01 Diagnosing COL6-Related Disorders And Methods For Treating Same US 62/358,482 Abandoned
NIAID E-174-2016-0-US-01 Use of an Inhibitor of Heme Degradation To Improve Antibiotic Treatment Of Mycobacterium Tuberculosis Infection US 62/357,558 Abandoned
NHLBI E-120-2016-0-US-01 HERV-E REACTIVE T CELL RECEPTORS AND METHODS OF USE US 62/357,265 Abandoned
NCI E-295-2012-0-GB-09 Anti-Viral Cnidarins GB EP 15701450.7 Issued
NCI E-295-2012-0-DE-07 Anti-Viral Cnidarins DE EP 15701450.7 Issued
NCI E-295-2012-0-FR-08 Anti-Viral Cnidarins FR EP 15701450.7 Issued
NCI E-193-2015-0-PCT-02 METHODS OF CHARACTERIZING ADRENOCORTICAL TUMORS PCT PCT PCT/US2016/040148 Expired
NCI E-193-2015-0-EP-03 METHODS OF CHARACTERIZING ADRENOCORTICAL TUMORS EP National Stage 16739339.6 Abandoned
NCATS E-190-2016-0-US-01 Small Molecule Inhibitors Of Lactate Dehydrogenase and Methods of Use Thereof US 62/356,065 Abandoned
NIAID E-139-2006-0-US-27 Development Of Dengue Virus Vaccine Components US CON 15/195,406 Abandoned
NLM E-107-2010-2-US-04 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US CON 15/193,796 10443091 Issued PDF
NIAID E-270-2015-0-US-01 SELF-ASSEMBLING INSECT FERRITIN NANOPARTICLES FOR DISPLAY OF CO-ASSEMBLED TRIMERIC ANTIGENS US 62/355,212 Abandoned
NCATS E-230-2016-1-US-01 Tools To Develop A Therapy For The Treatment Of Zellweger Spectrum Disorder US 62/355,247 Abandoned
NCI E-069-2016-0-US-01 Therapeutic Antitumor Combination Of A TLR4 Ligand With Other Treatments US 62/355,134 Abandoned
NICHD E-120-2015-0-EP-19 Method For On-demand Contraception EP DIV 16181168.2 Abandoned
NCI E-235-2015-0-US-03 METHODS FOR THE TREATMENT OF KAPOSI'S SARCOMA OR KSHV-INDUCED LYMPHOMA
USING IMMUNOMODULATORY COMPOUNDS, AND USES OF BIOMARKERS 		US ORD 15/192,819 10001483 Issued PDF
NCI E-235-2015-0-PCT-02 Methods for the Treatment of Kaposi's Sarcoma or KSHV-Induced Lymphoma Using Immunomodulatory Compounds, and Uses of Biomarkers PCT PCT PCT/US2016/039245 Expired
NIAID E-283-2009-1-US-07 Compounds That Treat Malaria and Prevent Malaria Transmission US DIV 15/192,779 Abandoned
NCI E-264-2011-0-US-07 Delivery Of Packaged RNA In Mammalian Cells US DIV 15/190,992 10538743 Issued PDF